Leerink Partners analyst Puneet Souda maintained a Buy rating on Bio-Techne (TECH – Research Report) yesterday. The company’s shares closed
Tag: NASDAQ:TECH
A Director at Bio-Techne is Exercising Options
Yesterday it was reported that a Director at Bio-Techne (TECH – Research Report), Robert Baumgartner, exercised options to sell 5,000
The CFO of Bio-Techne is Exercising Options
Yesterday it was reported that the CFO of Bio-Techne (TECH – Research Report), James Hippel, exercised options to sell 15,909
Bio-Techne (TECH) Gets a Buy Rating from Atlantic Equities
In a report released yesterday, Atlantic Equities from Atlantic Equities initiated coverage with a Buy rating on Bio-Techne (TECH –
The President-Protein Sciences of Bio-Techne is Exercising Options
Yesterday it was reported that the President-Protein Sciences of Bio-Techne (TECH – Research Report), David Eansor, exercised options to sell
The President-Protein Sciences of Bio-Techne (NASDAQ: TECH) is Selling Shares
Yesterday, the President-Protein Sciences of Bio-Techne (TECH – Research Report), David Eansor, sold shares of TECH for $275.6K. Following David
The CEO of Bio-Techne Corporation is Exercising Options
Yesterday it was reported that the CEO of Bio-Techne Corporation (TECH – Research Report), Charles Kummeth, exercised options to buy